Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

International cancer seminars: a focus on kidney cancer

G. Scelo, JN. Hofmann, RE. Banks, P. Bigot, RS. Bhatt, G. Cancel-Tassin, SK. Chew, CJ. Creighton, O. Cussenot, IJ. Davis, B. Escudier, TM. Frayling, C. Häggström, MA. Hildebrandt, I. Holcatova, M. Johansson, WM. Linehan, DF. McDermott, KL....

. 2016 ; 27 (8) : 1382-5. [pub] 20160429

Language English Country Great Britain

Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc18017281

Recent years have seen important advances in our understanding of the etiology, biology and genetics of kidney cancer. To summarize important achievements and identify prominent research questions that remain, a workshop was organized by IARC and the US NCI. A series of 'difficult questions' were formulated, which should be given future priority in the areas of population, genomic and clinical research.

Clinical and Biomedical Proteomics Group Cancer Research UK Centre Leeds Institute for Cancer Studies and Pathology St James' University Hospital Leeds UK

Department of Epidemiology Division of OVP Cancer Prevention and Population Sciences The University of Texas MD Anderson Cancer Center Houston USA

Department of Epidemiology The University of Texas MD Anderson Cancer Center Houston USA

Department of Genetics UNC School of Medicine Chapel Hill USA

Department of Medical Oncology Institut Gustave Roussy Villejuif France

Department of Medicine University of Pennsylvania Philadelphia USA

Department of Pathology Northwestern University Feinberg School of Medicine Robert H Lurie Comprehensive Cancer Center Chicago USA

Department of Surgical and Perioperative Sciences Urology and Andrology Umeå University Umeå

Department of Surgical and Perioperative Sciences Urology and Andrology Umeå University Umeå Department of Biobank Research Umeå University Umeå Sweden

Department of Urology Centre Hospitalier Universitaire d'Angers Angers France

Division of Cancer Epidemiology and Genetics Department of Health and Human Service National Cancer Institute National Institutes of Health Bethesda USA

Division of Hematology Oncology Beth Israel Deaconess Medical Center Kidney Cancer Program Dana Farber Harvard Cancer Center Boston MA USA

Duncan Cancer Center Biostatistics Baylor College of Medicine Houston

Graduate School of Medicine University of Tokyo Tokyo Japan

Groupe de Recherche GRC UPMC n°5 Centre de Recherche sur les Pathologies Prostatiques et Urologiques Paris France

Institute of Public Health and Preventive Medicine Charles University 2nd Faculty of Medicine Prague Czech Republic

Section of Genetics International Agency for Research on Cancer Lyon France

Translational Cancer Therapeutics Laboratory UCL Cancer Institute University College London London UK

University College London Hospitals and Cancer Institute London UK

University of Exeter Medical School Exeter UK

Urologic Oncology Branch Center for Cancer Research National Cancer Institute Bethesda

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18017281
003      
CZ-PrNML
005      
20180515103126.0
007      
ta
008      
180515s2016 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/annonc/mdw186 $2 doi
035    __
$a (PubMed)27130845
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Scelo, G $u Section of Genetics, International Agency for Research on Cancer, Lyon, France.
245    10
$a International cancer seminars: a focus on kidney cancer / $c G. Scelo, JN. Hofmann, RE. Banks, P. Bigot, RS. Bhatt, G. Cancel-Tassin, SK. Chew, CJ. Creighton, O. Cussenot, IJ. Davis, B. Escudier, TM. Frayling, C. Häggström, MA. Hildebrandt, I. Holcatova, M. Johansson, WM. Linehan, DF. McDermott, KL. Nathanson, S. Ogawa, EJ. Perlman, MP. Purdue, P. Stattin, C. Swanton, NS. Vasudev, X. Wu, A. Znaor, P. Brennan, SJ. Chanock,
520    9_
$a Recent years have seen important advances in our understanding of the etiology, biology and genetics of kidney cancer. To summarize important achievements and identify prominent research questions that remain, a workshop was organized by IARC and the US NCI. A series of 'difficult questions' were formulated, which should be given future priority in the areas of population, genomic and clinical research.
650    _2
$a biomedicínský výzkum $7 D035843
650    12
$a genomika $7 D023281
650    _2
$a lidé $7 D006801
650    _2
$a nádory ledvin $x etiologie $x genetika $x patologie $7 D007680
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hofmann, J N $u Division of Cancer Epidemiology and Genetics, Department of Health and Human Service, National Cancer Institute, National Institutes of Health, Bethesda, USA.
700    1_
$a Banks, R E $u Clinical and Biomedical Proteomics Group, Cancer Research UK Centre, Leeds Institute for Cancer Studies and Pathology, St James' University Hospital, Leeds, UK.
700    1_
$a Bigot, P $u Department of Urology, Centre Hospitalier Universitaire d'Angers, Angers, France.
700    1_
$a Bhatt, R S $u Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Kidney Cancer Program, Dana-Farber/Harvard Cancer Center, Boston, MA, USA.
700    1_
$a Cancel-Tassin, G $u Groupe de Recherche GRC-UPMC n°5, Centre de Recherche sur les Pathologies Prostatiques et Urologiques (CeRePP), Paris, France.
700    1_
$a Chew, S K $u Translational Cancer Therapeutics Laboratory, UCL Cancer Institute, University College London, London, UK.
700    1_
$a Creighton, C J $u Duncan Cancer Center-Biostatistics, Baylor College of Medicine, Houston.
700    1_
$a Cussenot, O $u Groupe de Recherche GRC-UPMC n°5, Centre de Recherche sur les Pathologies Prostatiques et Urologiques (CeRePP), Paris, France.
700    1_
$a Davis, I J $u Department of Genetics, UNC School of Medicine, Chapel Hill, USA.
700    1_
$a Escudier, B $u Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.
700    1_
$a Frayling, T M $u University of Exeter Medical School, Exeter, UK.
700    1_
$a Häggström, C $u Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå Department of Biobank Research, Umeå University, Umeå, Sweden.
700    1_
$a Hildebrandt, M A T $u Department of Epidemiology, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, USA.
700    1_
$a Holcatova, I $u Institute of Public Health and Preventive Medicine, Charles University, 2nd Faculty of Medicine, Prague, Czech Republic.
700    1_
$a Johansson, M $u Section of Genetics, International Agency for Research on Cancer, Lyon, France.
700    1_
$a Linehan, W M $u Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda.
700    1_
$a McDermott, D F $u Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Kidney Cancer Program, Dana-Farber/Harvard Cancer Center, Boston, MA, USA.
700    1_
$a Nathanson, K L $u Department of Medicine, University of Pennsylvania, Philadelphia, USA.
700    1_
$a Ogawa, S $u Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
700    1_
$a Perlman, E J $u Department of Pathology, Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, USA.
700    1_
$a Purdue, M P $u Division of Cancer Epidemiology and Genetics, Department of Health and Human Service, National Cancer Institute, National Institutes of Health, Bethesda, USA.
700    1_
$a Stattin, P $u Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå
700    1_
$a Swanton, C $u University College London Hospitals and Cancer Institute, London, UK.
700    1_
$a Vasudev, N S $u Clinical and Biomedical Proteomics Group, Cancer Research UK Centre, Leeds Institute for Cancer Studies and Pathology, St James' University Hospital, Leeds, UK.
700    1_
$a Wu, X $u Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, USA.
700    1_
$a Znaor, A $u Section of Genetics, International Agency for Research on Cancer, Lyon, France.
700    1_
$a Brennan, P $u Section of Genetics, International Agency for Research on Cancer, Lyon, France brennanp@iarc.fr.
700    1_
$a Chanock, S J $u Division of Cancer Epidemiology and Genetics, Department of Health and Human Service, National Cancer Institute, National Institutes of Health, Bethesda, USA brennanp@iarc.fr.
773    0_
$w MED00000432 $t Annals of oncology official journal of the European Society for Medical Oncology $x 1569-8041 $g Roč. 27, č. 8 (2016), s. 1382-5
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27130845 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180515103300 $b ABA008
999    __
$a ok $b bmc $g 1300905 $s 1014121
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 27 $c 8 $d 1382-5 $e 20160429 $i 1569-8041 $m Annals of oncology $n Ann Oncol $x MED00000432
LZP    __
$a Pubmed-20180515

Find record

Citation metrics

Archiving options